Reliability of Quantitative Real-Time PCR for Bacterial Detection in Cystic Fibrosis Airway Specimens
暂无分享,去创建一个
J. Harris | F. Accurso | S. Sagel | Mark J. Stevens | B. Wagner | E. Zemanick | J. Kirk Harris | Brandie D. Wagner | Edith T. Zemanick | J. K. Harris
[1] D. Goldmann,et al. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent , 1980, Journal of clinical microbiology.
[2] M. Navazesh,et al. Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.
[3] D H Persing,et al. Molecular diagnostics of infectious diseases , 1999 .
[4] N. Pace. A molecular view of microbial diversity and the biosphere. , 1997, Science.
[5] R. Proctor,et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. , 1998, The Journal of infectious diseases.
[6] J. Emerson,et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] J. Emerson,et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis , 1999, Pediatric pulmonology.
[8] P. Beringer,et al. Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features , 2000, Current opinion in pulmonary medicine.
[9] A. van Belkum,et al. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients. , 2000, FEMS immunology and medical microbiology.
[10] F. Accurso,et al. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. , 2001, American journal of respiratory and critical care medicine.
[11] Neil Hunter,et al. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.
[12] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[13] D. Rennie,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.
[14] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[15] Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling , 2003, Journal of Clinical Microbiology.
[16] C. E. Caldon,et al. Carious Dentine Provides a Habitat for a Complex Array of Novel Prevotella-Like Bacteria , 2004, Journal of Clinical Microbiology.
[17] G. Rogers,et al. Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling , 2004, Journal of Clinical Microbiology.
[18] L. Saiman. Microbiology of early CF lung disease. , 2004, Paediatric respiratory reviews.
[19] P. Savelkoul,et al. Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. , 2005, FEMS immunology and medical microbiology.
[20] V. Raia,et al. BMC Infectious Diseases BioMed Central Research article , 2006 .
[21] M. Surette,et al. Cystic fibrosis: a polymicrobial infectious disease. , 2006, Future microbiology.
[22] P. Morris,et al. Bmc Ear, Nose and Throat Disorders Open Access Measuring Nasal Bacterial Load and Its Association with Otitis Media , 2022 .
[23] G. Rogers,et al. Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis , 2006, Journal of Clinical Microbiology.
[24] T. Asahara,et al. Sensitive Quantitative Detection of Commensal Bacteria by rRNA-Targeted Reverse Transcription-PCR , 2006, Applied and Environmental Microbiology.
[25] P. Savelkoul,et al. Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. , 2007, Journal of periodontology.
[26] N. Pace,et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.
[27] P. Berche,et al. Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children. , 2007, Journal of microbiological methods.
[28] J. Sarles,et al. Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients , 2008, PloS one.
[29] H. D. Vanguilder,et al. Twenty-five years of quantitative PCR for gene expression analysis. , 2008, BioTechniques.
[30] M. Wolfgang,et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.
[31] S. Molin,et al. In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections , 2007, Journal of bacteriology.
[32] R. Knight,et al. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex , 2008, Nature Methods.
[33] P. Brigidi,et al. Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study , 2008, European Journal of Clinical Microbiology & Infectious Diseases.
[34] M. Surette,et al. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients , 2008, Proceedings of the National Academy of Sciences.
[35] E. Goldstein,et al. National hospital survey of anaerobic culture and susceptibility methods: III. , 2008, Anaerobe.
[36] B. Rubin. Mucus, phlegm, and sputum in cystic fibrosis. , 2009, Respiratory care.
[37] G. Döring,et al. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[38] J. Harris,et al. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures , 2010, Pediatric pulmonology.
[39] J. Rolain,et al. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.